The Nasdaq Composite moved lower, with Coinbase Global and Mersana Therapeutics playing significant roles
Image by Unsplash
Coinbase Global's shares went down 5% due to falling crypto prices and regulatory pressure
Image by Unsplash
Bitcoin fell by more than $1,000, dropping below $25,000, and Ethereum lost roughly $100 to around $1,640, impacting Coinbase's trading fee
Image by Unsplash
Coinbase faces a regulatory threat from the U.S. Securities and Exchange Commission, which could take months or even years to resolve
Image by Unsplash
Mersana Therapeutics lost 58% due to bad news from the U.S. Food and Drug Administration (FDA) about their ovarian cancer treatment
Image by Unsplash
Five fatal bleeding events among the 560 patients in the trial led to the FDA placing a partial clinical hold on Mersana's trials
Image by Unsplash
Despite the setbacks, both companies strive to overcome their challenges. Stay tuned for more updates in this financial roller coaster
Image by Unsplash